NYSE : DLB

Dolby Laboratories, Inc.

$51.27 USD

$1.41 (2.83%)

Volume
814.95K
Average Volume
906.14K
Market Capitalization
$4.9B
P/E Ratio
20.03
Dividend Yield
2.75%
Price Target
$85.00
Year High
$76.70
Year Low
$48.26
Day High
Day Low
Payout Ratio
$0.54
Current Ratio
$2.98
Company Overview

NYSE

Kevin J. Yeaman

Information Technology Services

Technology

DLB

2051

US

USD

415 558 0200

25659T107

0001308547

Liquidity Metrics

0.02

2.98

2.91

1.25

0.54

Sales & Valuation

$1.35B

3.59

1.86

18.98

2.71

Profitability

$2.62

$255.02M

17.85%

21.14%

9.34%

7.50%

P/E Metrics

20.03

-4.86

-4.86

Analyst Price Target & Rating

$85.00

$112.00

$74.00

Buy

4/5

17 Analysts

-39.68%

Financial Health Scores

6.78

6/9

$940.1M

$3.25B

$622.36M

$278.32M

Key Metrics (TTM)

$4.22B

3.09

11.08

2.98

9.34%

7.78%

5.13%

5.42%

$39.79

192 days

Company Executives
Name Title
Todd Pendleton Senior Vice President & Chief Marketing Officer
John D. Couling Senior Vice President of Entertainment
Kevin J. Yeaman President, Chief Executive Officer & Director
Andy Sherman Executive Vice President, General Counsel & Corporate Secretary
Edwin Marin Senior Vice President & Chief Information Officer
Peter L. Goldmacher Vice President of Investor Relations
Linda Rogers Senior Vice President & Chief People Officer
Shriram Revankar Senior Vice President of Advanced Technology Group
Robert J. Park Senior Vice President & Chief Financial Officer
Ryan Nicholson Vice President, Corporate Controller & Chief Accounting Officer
Poll Results

No votes yet today — be the first to share your view!

About Dolby Laboratories, Inc. (NYSE:DLB) Stock

Dolby Laboratories, Inc. develops pioneering audio and visual technologies designed to enhance entertainment and communication experiences across a broad spectrum of platforms. These include cinematic venues, digital television, various transmission and playback devices, mobile communications, online streaming video and music platforms, and home entertainment systems. The company is actively involved in inventing and licensing its advanced sound technologies. This portfolio features solutions like AAC & HE-AAC, a digital audio codec widely adopted for diverse media applications; AVC, a digital video codec recognized for its efficient bandwidth utilization in various media devices; Dolby AC-4, an innovative digital audio coding standard that introduces new auditory experiences to numerous p ... layback systems; and the immersive Dolby Atmos technology, utilized in both cinemas and a wide array of consumer devices. Additional audio innovations encompass Dolby Digital, which delivers multichannel sound to various applications; Dolby Digital Plus, facilitating audio transmission for a multitude of media uses and devices; and Dolby TrueHD, a digital audio coding technology focused on media content encoding. Its imaging solutions include Dolby Vision, an advanced visual technology for film and media devices; Dolby Voice, specialized for audio conferencing; and HEVC, another digital video codec valued for its bandwidth efficiency in supporting media devices. Beyond its software and licensing activities, Dolby also designs and manufactures tangible products. This range includes digital cinema servers, professional cinema processors, amplifiers, loudspeakers, various hardware components, and video conferencing equipment. These products cater to the film, television, broadcasting, telecommunications, and broader entertainment industries. Furthermore, the corporation offers a variety of services to support theatrical and television production, spanning cinematic exhibition, broadcast operations, and home entertainment solutions. Dolby's diverse client base includes prominent film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. The company distributes its offerings directly to end-users, as well as through a global network of dealers and distributors. Founded in 1965, Dolby Laboratories, Inc. has its main offices located in San Francisco, California.

Dolby Laboratories Valuation Is Compelling Ahead Of Earnings

2026-07-20 10:18:12

Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x FCF and 19.7x earnings. DLB's revenue growth remains choppy, but licensing—especially in Broadcast and Mobile—drives solid results and offers mid-single-digit growth potential. Expansion into automotive and increased adoption of Dolby Atmos/Vision by major platforms and automakers support future growth, with modest price increases feasible.

Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2026 Financial Results

2026-07-14 16:15:00

SAN FRANCISCO, July 14, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the third quarter (Q3) fiscal year 2026 after the close of regular trading on Thursday, July 30, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q3 fiscal year 2026 financial results for Dolby Laboratories at 2:00 p.m.

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

2026-07-14 07:30:00

BOSTON, July 14, 2026 (GLOBE NEWSWIRE) -- CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain

2026-06-26 10:07:20

Cognition Therapeutics is currently prioritizing zervimesine for DLB psychosis. This is after the FDA's feedback gave their planned pivotal program a clearer path. Basically, DLB psychosis has no approved therapy, and zervimesine is a promising oral once-daily drug that already has interesting Phase 2 data. CGTX's SHIMMER trial was a good start, but their next trial must confirm longer-lasting hallucination and delusion benefits.

Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes

2026-06-24 07:30:00

- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Disease - - Company Developing NPI as a Measure of DLB Psychosis -

3 Audio Video Stocks to Watch as Industry Witnesses Headwinds

2026-06-10 14:00:48

Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and SONO.

Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics

2026-06-09 10:00:00

Arista Networks (NYSE: ANET), a leader in modern AI fabric networking, today announced the Arista [url="]7060XE7 Series[/url], a new portfolio of 1.6T networki

Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming First

2026-06-05 11:00:00

Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming First PR Newswire

Frequently Asked Questions

What is the current Dolby Laboratories, Inc. (DLB) stock price?

Dolby Laboratories, Inc.(NYSE:DLB) stock price is $51.27 in the last trading session. During the trading session, DLB stock reached the peak price of $76.7 while $48.26 was the lowest point it dropped to. The percentage change in DLB stock occurred in the recent session was 2.83% while the dollar amount for the price change in DLB stock was $1.41.

DLB's industry and sector of operation?

The NYSE listed DLB is part of Information Technology Services industry that operates in the broader Technology sector.

Who are the executives of DLB?

Todd Pendleton | Senior Vice President & Chief Marketing Officer
John D. Couling | Senior Vice President of Entertainment
Kevin J. Yeaman | President, Chief Executive Officer & Director
Andy Sherman | Executive Vice President, General Counsel & Corporate Secretary
Edwin Marin | Senior Vice President & Chief Information Officer

How many employees does DLB have?

Number of DLB employees currently stands at 2051. DLB operates from 1275 Market Street, San Francisco, CA 94103-1410, US.

Link for DLB official website?

Official Website of DLB is: https://www.dolby.com

How do I contact DLB?

DLB could be contacted at phone #415 558 0200 and can also be accessed through its website. DLB operates from 1275 Market Street, San Francisco, CA 94103-1410, US.

How many shares of DLB are traded daily?

The average number of DLB shares traded daily for last 3 months was 906.14K.

What is the market cap of DLB currently?

The market value of DLB currently stands at $4.9B with its latest stock price at $51.27